News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
428,272 Results
Type
Article (20625)
Company Profile (120)
Press Release (407527)
Section
Business (125747)
Career Advice (774)
Deals (21921)
Drug Delivery (33)
Drug Development (60650)
Employer Resources (54)
FDA (11353)
Job Trends (9144)
News (220045)
Policy (18407)
Tag
Academia (1498)
Alliances (30489)
Alzheimer's disease (830)
Approvals (11322)
Artificial intelligence (101)
Bankruptcy (159)
Best Places to Work (7733)
Biotechnology (105)
Breast cancer (149)
Cancer (1129)
Career advice (652)
CAR-T (80)
Cell therapy (238)
Clinical research (49233)
Collaboration (338)
Compensation (150)
COVID-19 (1910)
C-suite (84)
Cystic fibrosis (71)
Data (1146)
Diabetes (89)
Diagnostics (3926)
Earnings (52125)
Events (68603)
Executive appointments (267)
FDA (11920)
Funding (288)
Gene therapy (126)
GLP-1 (332)
Government (2225)
Healthcare (11803)
Infectious disease (1988)
Inflammatory bowel disease (89)
Interviews (110)
IPO (11038)
Job creations (1731)
Job search strategy (576)
Layoffs (213)
Legal (3343)
Lung cancer (171)
Lymphoma (82)
Manufacturing (117)
Medical device (9562)
Medtech (9565)
Mergers & acquisitions (11029)
Metabolic disorders (256)
Neuroscience (1053)
NextGen Class of 2024 (3777)
Non-profit (2123)
Northern California (1318)
Obesity (141)
Opinion (91)
People (35917)
Phase I (15868)
Phase II (22009)
Phase III (16186)
Pipeline (424)
Postmarket research (1455)
Preclinical (5774)
Radiopharmaceuticals (174)
Rare diseases (196)
Real estate (3388)
Regulatory (13826)
Research institute (1519)
Resumes & cover letters (133)
Southern California (1070)
Startups (2042)
United States (11062)
Vaccines (493)
Weight loss (79)
Date
Today (90)
Last 7 days (434)
Last 30 days (1752)
Last 365 days (25737)
2024 (25628)
2023 (29294)
2022 (37196)
2021 (39900)
2020 (37130)
2019 (29136)
2018 (22232)
2017 (21615)
2016 (19918)
2015 (24282)
2014 (17787)
2013 (13881)
2012 (14740)
2011 (15444)
2010 (14221)
Location
Africa (354)
Arizona (84)
Asia (23674)
Australia (4073)
California (2852)
Canada (999)
China (203)
Colorado (116)
Connecticut (125)
Europe (53347)
Florida (408)
Georgia (93)
Illinois (215)
Indiana (176)
Japan (71)
Kansas (73)
Maryland (451)
Massachusetts (2229)
Michigan (136)
Minnesota (215)
New Jersey (814)
New York (817)
North Carolina (549)
Northern California (1318)
Ohio (103)
Pennsylvania (635)
South America (488)
Southern California (1070)
Texas (381)
Washington State (338)
428,272 Results for "immune design corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced Melanoma
December 12, 2024
·
6 min read
Press Releases
Immuneering Granted Orphan Drug Designation for IMM-1-104 by FDA in the Treatment of Pancreatic Cancer
October 15, 2024
·
6 min read
Press Releases
Orion Corporation Enters Collaboration With Evariste to Design Inhibitors of an Undisclosed Target
December 10, 2024
·
2 min read
Genetown
Immuneering Receives FDA Fast Track Designation for IMM-1-104 in Pancreatic Cancer
Immuneering Corporation (Nasdaq: IMRX) today announced that the U.S. Food and Drug Administration (FDA) granted Fast Track designation for its lead clinical-stage program, IMM-1-104, for the treatment of patients with pancreatic ductal adenocarcinoma (PDAC) who have failed one line of treatment.
February 20, 2024
·
5 min read
Biotech Bay
Immune-Onc Therapeutics Announces Orphan Drug Designation Granted by US FDA for IO-202 (Anti-LILRB4) for the Treatment of Chronic Myelomonocytic Leukemia (CMML)
Immune-Onc Therapeutics, Inc. (“Immune-Onc”), a clinical-stage biopharmaceutical company advancing novel therapies in immunology and oncology by targeting myeloid cell inhibitory receptors, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for IO-202 for the treatment of chronic myelomonocytic leukemia (CMML).
February 21, 2024
·
6 min read
Press Releases
AC Immune’s PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions
August 28, 2024
·
5 min read
Press Releases
AC Immune’s ACI-35.030 (now “JNJ-2056”) Granted FDA Fast Track Designation for Alzheimer’s Disease
July 25, 2024
·
6 min read
FDA
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis
DURECT Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation (BTD) to larsucosterol for the treatment of patients with severe alcohol-associated hepatitis (AH).
May 21, 2024
·
9 min read
Partnered
From Theory to Practice: Johns Hopkins Design Team Sets Undergrads Up for Success
At Johns Hopkins University, the biomedical engineering program’s Design Team offering lets undergraduates dive deep into clinical projects that can help them land industry jobs, get provisional patents or even start companies.
November 6, 2024
·
6 min read
·
BioSpace Insights
Press Releases
AC Immune Reports Third Quarter 2024 Financial Results and Provides a Corporate Update
November 5, 2024
·
11 min read
1 of 42,828
Next